The StreetWise Investor ®
Timely News, Ideas and Strategies for Active Investors
Monday, January 28, 2008
Medtronic Begins Trials on New Pacemaker...
MDT up .30 to $46.42
Medtronic (MDT) announces FDA approval to begin clinical trial of first pacemaker system designed for safe use in MRI machines.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment